This blog was originally published by the Dengue Vaccine Initiative.

Every three months, the Dengue Vaccine Initiative (DVI) highlights a “Dengue Champion,” calling attention to that person’s contribution to the dengue vaccine research field and their commitment to the fight against dengue fever. Dr.

Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.

Pages